English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [524]
News [1468]
Articles [68]
Editorials [2]
Conferences [72]
elearning [5]
Ipilimumab improves survival in metastatic melanoma
Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Ipilimumab improves survival in metastatic melanoma ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
17 Jun 2011
New melanoma drug gives 63 percent reduction in risk of death compared to...
Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center
New melanoma drug gives 63 percent reduction in risk of death compared to dacarbazine ( Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center )
17 Jun 2011
ASCO 2011 highlights
Prof Gordon McVie – ecancer Managing Editor
ASCO 2011 highlights ( Prof Gordon McVie – ecancer Managing Editor )
16 Jun 2011
The future of medicine: personalised
Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany
The future of medicine: personalised ( Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany )
2 Jun 2011
Reducing global cancer mortality
Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Reducing global cancer mortality ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
2 Jun 2011
The Cancer Genome Atlas (TCGA)
Dr Paul Spellman - National Cancer Institute, Bethesda, USA
The Cancer Genome Atlas (TCGA) ( Dr Paul Spellman - National Cancer Institute, Bethesda, USA )
21 Apr 2011
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity
Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity ( Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA )
20 Apr 2011
Ethical considerations surrounding cancer in the elderly and the pros and cons...
Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen...
Ethical considerations surrounding cancer in the elderly and the pros and cons of web-based resources ( Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen Verschuur (Europa Donna) )
17 Mar 2011
Treatment of brain metastases in melanoma patients
Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander...
Treatment of brain metastases in melanoma patients ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands )
7 Feb 2011
Sarah Cannon Research Institute research developments at ASCO 2010
Dr Howard Burris, The Sarah Cannon Research Institute, Nashville
Sarah Cannon Research Institute research developments at ASCO 2010 ( Dr Howard Burris, The Sarah Cannon Research Institute, Nashville )
4 Feb 2011
Clinical benefits and side effects of ipilimumab in melanoma patients
Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy
Clinical benefits and side effects of ipilimumab in melanoma patients ( Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy )
31 Jan 2011
Molecular chaperones: cancer dependence and druggability
Prof Paul Workman - The Institute of Cancer Research, Sutton, UK
Molecular chaperones: cancer dependence and druggability ( Prof Paul Workman - The Institute of Cancer Research, Sutton, UK )
19 Jan 2011
<1...394041424344>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top